207 related articles for article (PubMed ID: 19607971)
1. Nociceptive behavior induced by the endogenous opioid peptides dynorphins in uninjured mice: evidence with intrathecal N-ethylmaleimide inhibiting dynorphin degradation.
Tan-No K; Takahashi H; Nakagawasai O; Niijima F; Sakurada S; Bakalkin G; Terenius L; Tadano T
Int Rev Neurobiol; 2009; 85():191-205. PubMed ID: 19607971
[TBL] [Abstract][Full Text] [Related]
2. Pronociceptive role of dynorphins in uninjured animals: N-ethylmaleimide-induced nociceptive behavior mediated through inhibition of dynorphin degradation.
Tan-No K; Takahashi H; Nakagawasai O; Niijima F; Sato T; Satoh S; Sakurada S; Marinova Z; Yakovleva T; Bakalkin G; Terenius L; Tadano T
Pain; 2005 Feb; 113(3):301-309. PubMed ID: 15661437
[TBL] [Abstract][Full Text] [Related]
3. Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-D-aspartate receptor mechanism.
Tan-No K; Esashi A; Nakagawasai O; Niijima F; Tadano T; Sakurada C; Sakurada T; Bakalkin G; Terenius L; Kisara K
Brain Res; 2002 Oct; 952(1):7-14. PubMed ID: 12363399
[TBL] [Abstract][Full Text] [Related]
4. Big dynorphin, a prodynorphin-derived peptide produces NMDA receptor-mediated effects on memory, anxiolytic-like and locomotor behavior in mice.
Kuzmin A; Madjid N; Terenius L; Ogren SO; Bakalkin G
Neuropsychopharmacology; 2006 Sep; 31(9):1928-37. PubMed ID: 16292317
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic effects of dynorphins through nonopioid intracellular mechanisms.
Tan-No K; Cebers G; Yakovleva T; Hoon Goh B; Gileva I; Reznikov K; Aguilar-Santelises M; Hauser KF; Terenius L; Bakalkin G
Exp Cell Res; 2001 Sep; 269(1):54-63. PubMed ID: 11525639
[TBL] [Abstract][Full Text] [Related]
6. Differential sensitivity of recombinant N-methyl-D-aspartate receptor subunits to inhibition by dynorphin.
Brauneis U; Oz M; Peoples RW; Weight FF; Zhang L
J Pharmacol Exp Ther; 1996 Dec; 279(3):1063-8. PubMed ID: 8968325
[TBL] [Abstract][Full Text] [Related]
7. Direct evidence for the ongoing brain activation by enhanced dynorphinergic system in the spinal cord under inflammatory noxious stimuli.
Taketa Y; Niikura K; Kobayashi Y; Furuya M; Shimizu T; Narita M; Imai S; Kuzumaki N; Maitani Y; Yamazaki M; Inada E; Iseki M; Suzuki T; Narita M
Anesthesiology; 2010 Feb; 112(2):418-31. PubMed ID: 20068450
[TBL] [Abstract][Full Text] [Related]
8. Dynorphin block of N-methyl-D-aspartate channels increases with the peptide length.
Chen L; Huang LY
J Pharmacol Exp Ther; 1998 Mar; 284(3):826-31. PubMed ID: 9495839
[TBL] [Abstract][Full Text] [Related]
9. Intrathecal high-dose histamine induces spinally-mediated nociceptive behavioral responses through a polyamine site of NMDA receptors.
Watanabe C; Orito T; Watanabe H; Mizoguchi H; Yonezawa A; Yanai K; Mobarakeh JI; Onodera K; Sakurada T; Sakurada S
Eur J Pharmacol; 2008 Feb; 581(1-2):54-63. PubMed ID: 18155693
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity analysis of dynorphin A toxicity in spinal cord neurons: intrinsic neurotoxicity of dynorphin A and its carboxyl-terminal, nonopioid metabolites.
Hauser KF; Knapp PE; Turbek CS
Exp Neurol; 2001 Mar; 168(1):78-87. PubMed ID: 11170722
[TBL] [Abstract][Full Text] [Related]
11. Neuropathic pain: the paradox of dynorphin.
Lai J; Ossipov MH; Vanderah TW; Malan TP; Porreca F
Mol Interv; 2001 Aug; 1(3):160-7. PubMed ID: 14993349
[TBL] [Abstract][Full Text] [Related]
12. Non-opioid nociceptive activity of human dynorphin mutants that cause neurodegenerative disorder spinocerebellar ataxia type 23.
Watanabe H; Mizoguchi H; Verbeek DS; Kuzmin A; Nyberg F; Krishtal O; Sakurada S; Bakalkin G
Peptides; 2012 Jun; 35(2):306-10. PubMed ID: 22531488
[TBL] [Abstract][Full Text] [Related]
13. Cysteine protease inhibitors suppress the development of tolerance to morphine antinociception.
Tan-No K; Shimoda M; Sugawara M; Nakagawasai O; Niijima F; Watanabe H; Furuta S; Sato T; Satoh S; Arai Y; Kotlinska J; Silberring J; Terenius L; Tadano T
Neuropeptides; 2008 Jun; 42(3):239-44. PubMed ID: 18440066
[TBL] [Abstract][Full Text] [Related]
14. [MK-801 suppresses dynorphin A (1-17)-induced facilitation of nociceptive responses to formalin in rats].
Qi WX; Lu CR
Sheng Li Xue Bao; 2003 Feb; 55(1):101-4. PubMed ID: 12598944
[TBL] [Abstract][Full Text] [Related]
15. Effects of extracellular pH on the dynorphin A inhibition of N-methyl-D-aspartate receptors expressed in Xenopus oocytes.
Oz M; Woods AS; Shippenberg T; Kaminski RM
Synapse; 2004 May; 52(2):84-8. PubMed ID: 15034914
[TBL] [Abstract][Full Text] [Related]
16. Dynorphin A activates bradykinin receptors to maintain neuropathic pain.
Lai J; Luo MC; Chen Q; Ma S; Gardell LR; Ossipov MH; Porreca F
Nat Neurosci; 2006 Dec; 9(12):1534-40. PubMed ID: 17115041
[TBL] [Abstract][Full Text] [Related]
17. Spinally administered dynorphin A produces long-lasting allodynia: involvement of NMDA but not opioid receptors.
Laughlin TM; Vanderah TW; Lashbrook J; Nichols ML; Ossipov M; Porreca F; Wilcox GL
Pain; 1997 Aug; 72(1-2):253-60. PubMed ID: 9272810
[TBL] [Abstract][Full Text] [Related]
18. A novel soluble protein factor with non-opioid dynorphin A-binding activity.
Marinova Z; Yakovleva T; Melzig MF; Hallberg M; Nylander I; Ray K; Rodgers DW; Hauser KF; Ekström TJ; Bakalkin G
Biochem Biophys Res Commun; 2004 Aug; 321(1):202-9. PubMed ID: 15358236
[TBL] [Abstract][Full Text] [Related]
19. Central non-opioid physiological and pathophysiological effects of dynorphin A and related peptides.
Shukla VK; Lemaire S
J Psychiatry Neurosci; 1992 Sep; 17(3):106-19. PubMed ID: 1356430
[TBL] [Abstract][Full Text] [Related]
20. Redox manipulation of NMDA receptors in vivo: alteration of acute pain transmission and dynorphin-induced allodynia.
Laughlin TM; Kitto KF; Wilcox GL
Pain; 1999 Mar; 80(1-2):37-43. PubMed ID: 10204716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
